{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-018299","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2026-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.441069+00:00","generated_at":"2026-05-15T05:06:12.897319+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Lipocine director Spyros Papapetropoulos resigns; R. Dana Ono appointed Chairman","bullets":["Spyros Papapetropoulos resigned from Lipocine Board effective April 16, 2026, citing competing commitments and differing views on strategic direction.","R. Dana Ono appointed Chairman and Lead Independent Director on April 20, 2026, replacing Papapetropoulos.","Papapetropoulos had served on the Board since 2022 and was Chairman prior to resignation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-018299","json":"https://secwatch.observer/filing/0001493152-26-018299.json","markdown":"https://secwatch.observer/filing/0001493152-26-018299.md","text":"https://secwatch.observer/filing/0001493152-26-018299.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226018299/0001493152-26-018299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226018299/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:06:12.897319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}